ArticleMolecular cancer2021

DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes.

Atish Kizhakeyil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.